The COVID-19 pandemic has created pressures to produce rapid research to inform policy and created a newly emerging field. Collabovid.org, a repository of COVID-19 research, found over 80,000 research papers are indexed COVID-19 (as of April 15, 2021). In a year’s time, it has become one of the most widely research topic area.
Overall aim: to enable and improve health economics evidence to inform COVID-related decisions and policies globally
In particular, Health economics research will be of particular interest to decision-makers to support them through critical decisions such as procurement of COVID-19 vaccines, planning and resourcing critical care beds or balancing COVID care with the needs of patients on other parts of the healthcare system.
For more information on how health economics can support COVID responses, see [link].
Despite the unequivocal benefits of health economics to inform decision-making, only in 2021 we are seeing an increase of such type of resources.
We have created this platform to enable and improve health economics evidence to inform COVID related decisions and policies in the world, with a focus on Low- and Middle-Income Countries (LMICs).
Our impact statement
We created the C19Economics.org to curate experiences, data, tools and analyses; and support health economists generate evidence for policy globally, with a focus on LMIC settings, in a demand driven and scientifically robust fashion. The goal is to facilitate the sharing of experiences and provide analysts with access to a focussed set of resources, a space to informally receive peer support and review, given the pressures to produce rapid results in an emerging field. In addition to supporting those who advice policy makers, we also aim to provide decision makers with a space to access analysts and summaries of relevant evidence, as it emerges’ directly to shape national and regional decision making
- Academics and analysts doing research and providing health economic policy advice on Covid-19 in LMICs (either working in Ministries, public health agencies or development partners) with a focus on building sustainable local capacity
- Policy makers and their advisors (technical staff) using economic and epi evidence to make decisions about policy response and more generally COVID and non COVID related allocation in the post COVID world with a focus on raising awareness and creating a demand for local/regional academic capacity
Partners of the platform
This platform has been funded by the Bill and Melinda Gates Foundation, Wellcome Trust, UK Foreign Commonwealth and Development Office and is supported by the International Decision Support Initiative (Center for Global Development, London School of Hygiene and Tropical Medicine, HITAP).